HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 154,353 shares of the company’s stock after selling 1,493 shares during the period. The Manufacturers Life Insurance Company owned 0.06% of HCA Healthcare worth $49,591,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $28,000. Bangor Savings Bank grew its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC grew its position in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. bought a new position in shares of HCA Healthcare during the first quarter worth about $33,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA opened at $403.28 on Monday. The company has a 50 day simple moving average of $378.91 and a 200-day simple moving average of $343.05. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The firm has a market capitalization of $105.62 billion, a price-to-earnings ratio of 20.10, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue was up 10.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.29 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Leerink Partners increased their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Truist Financial increased their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Finally, UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.